Inhibitory effect of geraniol in combination with gemcitabine on proliferation of BXPC-3 human pancreatic cancer cells

Journal of International Medical Research

Volumn 41, Issue 4, 2013, Pages 993-1001

  Jin, Xiaoxin ^a   Sun, Jichun ^b   Miao, Xiongyong ^a   Liu, Guoli ^a   Zhong, Dewu ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

BXPC 3 cells; combination; gemcitabine; Geraniol; human pancreatic cancer cells

Indexed keywords

GEMCITABINE; GERANIOL;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; DRUG POTENTIATION; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; MICROSCOPY; PANCREAS CANCER;

EID: 84887374617     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/0300060513480919     Document Type: Article

References (27)

1. Zhu CP,Shi J,Chen YX,et al.Gemcitabine in the chemoradiotherapy for locally advanced pancreatic cancer: a meta-analysis.Radiother Oncol. 2011;99:108-113.
2. Murakami Y,Uemura K,Sudo T,et al.Long-term results of adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for pancreatic carcinoma.J Surg Oncol. 2012;106:174-180.
3. Nakai Y,Isayama H,Sasaki T,et al.Comorbidity, not age, is prognostic in patients with advanced pancreatic cancer receiving gemcitabine-based chemotherapy.Crit Rev Oncol Hematol. 2011;78:252-259.
4. Vickers MM,Powell ED,Asmis TR,et al.Comorbidity, age and overall survival in patients with advanced pancreatic cancer - results from NCIC CTG PA.3: a phase III trial of gemcitabine plus erlotinib or placebo.Eur J Cancer. 2012;48:1434-1442.
5. Hung SW,Mody HR,Govindarajan R.Overcoming nucleoside analog chemoresistance of pancreatic cancer: a therapeutic challenge.Cancer Lett. 2012;320:138-149.
6. Heinemann V,Haas M,Boeck S.Systemic treatment of advanced pancreatic cancer.Cancer Treat Rev. 2012;38:843-853.
7. Kim SH,Bae HC,Park EJ,et al.Geraniol inhibits prostate cancer growth by targeting cell cycle and apoptosis pathways.Biochem Biophys Res Commun. 2011;407:129-134.
8. Ahmad ST,Arjumand W,Seth A,et al.Preclinical renal cancer chemopreventive efficacy of geraniol by modulation of multiple molecular pathways.Toxicology. 2011;290:69-81.
9. Duncan RE,Lau D,El-Sohemy A,et al.Geraniol and beta-ionone inhibit proliferation, cell cycle progression, and cyclin-dependent kinase 2 activity in MCF-7 breast cancer cells independent of effects on HMG-CoA reductase activity.Biochem Pharmacol. 2004;68:1739-1747.
10. Cardozo MT,de Conti A,Ong TP,et al.Chemopreventive effects of β-ionone and geraniol during rat hepatocarcinogenesis promotion: distinct actions on cell proliferation, apoptosis, HMGCoA reductase, and RhoA.J Nutr Biochem. 2011;22:130-135.
11. Carnesecchi S,Bras-Gonçalves R,Bradaia A,et al.Geraniol, a component of plant essential oils, modulates DNA synthesis and potentiates 5-fluorouracil efficacy on human colon tumor xenografts.Cancer Lett. 2004;215:53-59.
12. Hedberg M,Borgström A,Genell S,et al.Survival following pancreatic carcinoma: a follow-up study of all cases recorded in Malmö, Sweden, 1977-1991.Br J Surg. 1998;85:1641-1644.
13. Garcea G,Doucas H,Steward WP,et al.Hypoxia and angiogenesis in pancreatic cancer.ANZ J Surg. 2006;76:830-842.
14. Haddock G,Carter DC.Aetiology of pancreatic cancer.Br J Surg. 1990;77:1159-1166.
15. Silverman DT.Risk factors for pancreatic cancer: a case-control study based on direct interviews.Teratog Carcinog Mutagen. 2000;21:7-25.
16. Goodman KA,Hajj C.Role of radiation therapy in the management of pancreatic cancer.J Surg Oncol. 2013;107:86-96.
17. Bayraktar S,Rocha-Lima CM.Advanced or metastatic pancreatic cancer: molecular targeted therapies.Mt Sinai J Med. 2010;77:606-619.
18. O'Reilly EM.Adjuvant therapy for pancreas adenocarcinoma.J Surg Oncol. 2013;107:78-85.
19. Sauer-Heilborn A,Kath R,Schneider CP,et al.Severe non-haematological toxicity after treatment with gemcitabine.J Cancer Res Clin Oncol. 1999;125:637-640.
20. Gupta N,Ahmed I,Steinberg H,et al.Gemcitabine-induced pulmonary toxicity: case report and review of the literature.Am J Clin Oncol. 2002;25:96-100.
21. Van Cutsem E,Vervenne WL,Bennouna J,et al.Phase III trial of bevacizumab in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer.J Clin Oncol. 2009;27:2231-2237.
22. Arends JJ,Sleeboom HP,Leys MB,et al.A phase II study of rahitrexed and gemcitabine in patients with advanced pancreatic carcinoma.Br J Cancer. 2005;92:445-448.
23. Colucci G,Giuliani F,Gebbia V,et al.Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a prospective, randomized phase III study of the Gruppo Oncologia dell'Italia Meridionale.Cancer. 2002;94:902-910.
24. Kim SH,Park EJ,Lee CR,et al.Geraniol induces cooperative interaction of apoptosis and autophagy to elicit cell death in PC-3 prostate cancer cells.Int J Oncol. 2012;40:1683-1690.
25. Von Hoff DD,Ramesh K,Ramanathan RK,Borad MJ,et al.Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial.J Clin Oncol. 2011;29:4548-4554.
26. Adamo V,Lorusso V,Rossello R,et al.Pegylated liposomal doxorubicin and gemcitabine in the front-line treatment of recurrent/metastatic breast cancer: a multicentre phase II study.Br J Cancer. 2008;98:1916-1921.
27. Adachi S,Kokura S,Okayama T,et al.Effect of hyperthermia combined with gemcitabine on apoptotic cell death in cultured human pancreatic cancer cell lines.Int J Hyperthermia. 2009;25:210-219.